Dr. Yasmeen Attia is an Associate Professor of Pharmacology and Toxicology at The British University in Egypt and a Fulbright alumna. Her research focuses on how nuclear receptor modulation orchestrates the metabolic–immune interface in liver disease, particularly in metabolic dysfunction–associated steatohepatitis (MASH), hepatocellular carcinoma, and MASH-driven hepatocarcinogenesis.